Skip to main content

Want a detailed portfolio tracker?

FORTE SOFTWARE (FTRE) P/E (2023 - 2026)

FORTE SOFTWARE (FTRE) P/E from Jul 7, 2023 to Jun 3, 2026. The TTM FORTE SOFTWARE (FTRE) P/E is -3.19. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of FORTE SOFTWARE (FTRE)

YearP/EChange
2026-3.19+101.01%
2025-1.59-68.78%
2024-5.08-114.74%
202334.47N/A

Comparison FORTE SOFTWARE (FTRE) P/E with competitors

FORTE SOFTWARE (FTRE) P/E is -3.19.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.10-103.20%
ENLVEnlivex Therapeutics Ltd0.15-104.71%
FGENFibroGen Inc0.24-107.52%
TRAWTraws Pharma Inc0.47-114.82%
FBIOFortress Biotech Inc0.71-122.13%
CHRSCoherus Biosciences Inc0.98-130.66%
ORMPOramed Pharmaceuticals Inc1.47-146.19%
AGENAgenus Inc2.05-164.22%
VIVSVivoSim Labs Inc2.54-179.49%
INVAInnoviva Inc3.19-199.95%
CRMDCorMedix Inc3.65-214.29%
ABEOAbeona Therapeutics Inc4.20-231.82%
VXRTVaxart Inc4.26-233.59%
CVACCureVac N.V.4.45-239.36%
SRPTSarepta Therapeutics Inc4.62-244.96%
GLPGGalapagos NV4.86-252.32%
RIGLRigel Pharmaceuticals4.92-254.22%
ZVRAZevra Therapeutics Inc4.97-255.93%
ABUSArbutus Biopharma Corp5.69-278.49%
CGENCompugen Ltd7.38-331.48%
AUPHAurinia Pharmaceuticals Inc9.25-390.02%
ACADAcadia Pharmaceuticals Inc9.59-400.57%
OMEROmeros Corporation9.88-409.83%
PLXProtalix BioTherapeutics Inc9.91-410.64%
SPROSpero Therapeutics Inc10.73-436.52%
ADMAAdma Biologics Inc11.33-455.20%
SVASinovac Biotech Ltd11.44-458.51%
TBPHTheravance Biopharma Inc11.78-469.18%
HRMYHarmony Biosciences Holdings Inc12.18-481.84%
TGTXTG Therapeutics Inc13.18-513.16%
INCYIncyte Corp13.38-519.51%
SABSSAB Biotherapeutics Inc14.06-540.69%
XOMAXOMA Corp14.95-568.52%
REGNRegeneron Pharmaceuticals Inc14.98-569.61%
PBYIPuma Biotechnology Inc15.05-571.81%
EXELExelixis Inc15.79-595.15%
NAGENiagen Bioscience Inc16.35-612.71%
CPRXCatalyst Pharmaceuticals Inc17.34-643.74%
MDXGMimedx Group Inc17.38-644.70%
ARGXArgen X SE23.07-823.27%
HALOHalozyme Therapeutics Inc23.20-827.31%
XOMAOXOMA Corp25.34-894.53%
VRTXVertex Pharmaceuticals Inc25.66-904.28%
XOMAPXOMA Corp25.67-904.73%
CTMXCytomX Therapeutics Inc25.70-905.60%
ASNDAscendis Pharma A/S26.35-926.17%
RPRXRoyalty Pharma plc - Class A27.50-961.95%
SLNOSoleno Therapeutics Inc29.02-1009.60%
LGNDLigand Pharmaceuticals Inc - Class B30.19-1046.31%
BMRNBiomarin Pharmaceutical Inc37.51-1275.81%
APLSApellis Pharmaceuticals Inc39.02-1323.27%
KRYSKrystal Biotech Inc39.70-1344.47%
GMABGenmab40.20-1360.34%
ONCBeiGene Ltd67.03-2201.22%
TECHBio-Techne Corp68.59-2250.38%
VCELVericel Corp80.63-2627.64%
PHARPharming Group N.V.87.74-2850.56%
ALNYAlnylam Pharmaceuticals Inc124.93-4016.53%
TLXTelix Pharmaceuticals Ltd139.89-4485.42%
CORTCorcept Therapeutics Inc158.39-5065.33%